UBS Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-339
| Closed | -$614 | – | 8954 |
|
|
2023
Q2 | $614 | Sell |
339
-10,967
| -97% | -$19.9K | ﹤0.01% | 7079 |
|
|
2023
Q1 | $14.9K | Sell |
11,306
-4,921
| -30% | -$6.5K | ﹤0.01% | 6222 |
|
|
2022
Q4 | $27.4K | Sell |
16,227
-11,013
| -40% | -$18.6K | ﹤0.01% | 6164 |
|
|
2022
Q3 | $50K | Buy |
27,240
+3,576
| +15% | +$6.56K | ﹤0.01% | 5290 |
|
|
2022
Q2 | $72K | Buy |
23,664
+23,514
| +15,676% | +$71.5K | ﹤0.01% | 4664 |
|
|
2022
Q1 | $1K | Hold |
150
| – | – | ﹤0.01% | 8973 |
|
|
2021
Q4 | $2K | Sell |
150
-35
| -19% | -$467 | ﹤0.01% | 8746 |
|
|
2021
Q3 | $2K | Sell |
185
-1,465
| -89% | -$15.8K | ﹤0.01% | 7882 |
|
|
2021
Q2 | $16K | Buy |
+1,650
| New | +$16K | ﹤0.01% | 6501 |
|